A new drug for treating early-stage Alzheimer’s disease has been administered for the first time in Taiwan on an 83-year-old ...

The new medications are currently not covered by Taiwan’s health insurance system but are available to patients who can pay ...

Since then, the launch of Leqembi and Kisunla has renewed interest in the anti-amyloid approach, although early take-up of the new drugs has been slow due to their modest efficacy and potential to ...